Kevin L Knudtson

Title: Kevin L Knudtson: Innovator in Mycoplasma Research

Introduction

Kevin L Knudtson is a notable inventor based in Salt Lake City, UT (US). He has made significant contributions to the field of molecular biology, particularly in the development of expression systems for mycoplasma proteins. With a total of two patents to his name, Knudtson's work has implications for both research and clinical diagnostics.

Latest Patents

One of Knudtson's latest patents involves a mycoplasma expression system, specifically focusing on the mycoplasma arthritidis superantigen. The gene encoding the superantigen, known as the MAM gene, was molecularly cloned and modified through site-directed mutagenesis. This modification was crucial as it changed UGA codons, which are typically read as stop codons in universal systems, to UGG codons. This adjustment allowed the gene to be expressed in standard expression systems. The recombinant MAM, which includes additional amino acid residues at both the N- and C-termini, was found to be biologically active. Furthermore, certain amino acid substitutions in the active regions of the protein also resulted in biologically active MAM proteins. Knudtson's patent also discloses a method for diagnosing rheumatoid arthritis using recombinant MAM protein in an ELISA assay.

Career Highlights

Throughout his career, Kevin L Knudtson has worked with esteemed institutions such as the University of Utah Research Foundation and Iowa State University Research Foundation, Inc. His research has contributed to advancements in understanding mycoplasma-related diseases and their potential treatments.

Collaborations

Knudtson has collaborated with notable colleagues, including Barry C Cole and Curtis L Atkin. These partnerships have further enriched his research endeavors and have led to significant findings in the field.

Conclusion

Kevin L Knudtson's innovative work in mycoplasma research has paved the way for advancements in molecular biology and diagnostics. His contributions continue to impact the scientific community and hold promise for future developments in medical research.